These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27767088)
1. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Dey KK; Bharti R; Dey G; Pal I; Rajesh Y; Chavan S; Das S; Das CK; Jena BC; Halder P; Ray JG; Kulavi I; Mandal M Cancer Gene Ther; 2016 Nov; 23(11):382-391. PubMed ID: 27767088 [TBL] [Abstract][Full Text] [Related]
2. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells]. Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378 [No Abstract] [Full Text] [Related]
3. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Zhou G; Xie TX; Zhao M; Jasser SA; Younes MN; Sano D; Lin J; Kupferman ME; Santillan AA; Patel V; Gutkind JS; Ei-Naggar AK; Emberley ED; Watson PH; Matsuzawa SI; Reed JC; Myers JN Oncogene; 2008 Jun; 27(25):3527-38. PubMed ID: 18223693 [TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma. Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163 [TBL] [Abstract][Full Text] [Related]
5. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling. Li P; Xiao LY; Tan H Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744 [TBL] [Abstract][Full Text] [Related]
6. [Effects of S100A7 on the proliferation and invasiveness of esophageal squamous cell carcinoma EC9706 cells and possible mechanisms]. Qu Y; Liu H; Li S Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):144-7. PubMed ID: 24721357 [TBL] [Abstract][Full Text] [Related]
7. Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway. Cheng H; Wang W; Wang G; Wang A; Du L; Lou W Med Sci Monit; 2018 Feb; 24():768-781. PubMed ID: 29410394 [TBL] [Abstract][Full Text] [Related]
8. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma. Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697 [TBL] [Abstract][Full Text] [Related]
10. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837 [TBL] [Abstract][Full Text] [Related]
11. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959 [TBL] [Abstract][Full Text] [Related]
12. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma. Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212 [TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742 [TBL] [Abstract][Full Text] [Related]
14. The role of MAPK signaling pathway in formation of EMT in oral squamous carcinoma cells induced by TNF-α. Zhao XW; Zhou JP; Bi YL; Wang JY; Yu R; Deng C; Wang WK; Li XZ; Huang R; Zhang J; Tao DT Mol Biol Rep; 2019 Jun; 46(3):3149-3156. PubMed ID: 30989559 [TBL] [Abstract][Full Text] [Related]
15. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach. Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854 [TBL] [Abstract][Full Text] [Related]
16. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines. Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035 [TBL] [Abstract][Full Text] [Related]
17. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. Fang LY; Wong TY; Chiang WF; Chen YL J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021 [TBL] [Abstract][Full Text] [Related]
18. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y Oncology; 2005; 69(3):246-55. PubMed ID: 16127291 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
20. HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma. Carrera M; Bitu CC; de Oliveira CE; Cervigne NK; Graner E; Manninen A; Salo T; Coletta RD Int J Clin Exp Pathol; 2015; 8(4):3613-23. PubMed ID: 26097543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]